drugset / Trial / NCT02502032

Effects of Cisatracurium on Sccinylcholine-induced Fasciculations

NCT02502032

Phase 3 Completed 87 enrolled Zhuan Zhang
RandomizedParallel-groupQuadruple-blindPrevention

Summary

To investigate the effects of different doses of cisatracurium pretreatment on succinylcholine-induced fasciculations.

Timeline

Start
2015-07
Primary completion
2015-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisatracurium Small molecule 0.005 mg/kg
Subject Cisatracurium Small molecule 0.01 mg/kg
Subject Cisatracurium Small molecule 0.02 mg/kg

Indications

No indication recorded.